Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
03/30/2006 | WO2006032541A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
03/30/2006 | WO2006011024A3 New tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
03/30/2006 | WO2005123089A3 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
03/30/2006 | WO2005113536A3 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
03/30/2006 | WO2005047899A3 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation |
03/30/2006 | WO2005037825A3 Protein kinase inhibitors |
03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
03/30/2006 | US20060069144 Chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain; compounds have no or only minimal cardiovascular and/or sedatory activity; minimal side effects; 4-Benzo[1,2,5]thiadiazol-4-ylmethyl-1,3-dihydro-imidazole-2-thione |
03/30/2006 | US20060069143 4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
03/30/2006 | US20060069141 Trityl olmesartan medoxomil is reacted with an acid in a water miscible organic solvent, separating the precipitate of triphenyl carbinol from the solution of olmesartan medoxomil; solution of olmesartan medoxomil is treated with a base to obtain a precipitate of olmesartan medoxomil |
03/30/2006 | US20060069135 Benzimidazole derivatives and their use for modulating the gaba-a receptor complex |
03/30/2006 | US20060069126 Pharmaceutically active isoindoline derivatives |
03/30/2006 | US20060069112 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
03/30/2006 | US20060069103 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
03/30/2006 | US20060069090 Triazine compounds |
03/30/2006 | US20060069084 Methods of inhibiting kinases |
03/30/2006 | US20060069077 Receptor-type kinase modulators and methods of use |
03/30/2006 | US20060069028 A carbamate or urea containing comopound is useful to treat angiogeneisis; methionine aminopeptidase 2 (MetAP-2) coupled to a peptide prevents the metabolic degradation of the angiogenesis inhibitor compound |
03/30/2006 | DE102004046623A1 Neue Pyrimidin-Derivate und ihre Verwendung New pyrimidine derivatives and their use |
03/30/2006 | CA2582507A1 Compounds, compositions containing them, preparation thereof and uses thereof iii |
03/30/2006 | CA2582492A1 Novel pyrimidine derivatives and their use |
03/30/2006 | CA2581492A1 Indol derivatives as inhibitors of soluble adenylyl cyclase |
03/30/2006 | CA2581462A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
03/30/2006 | CA2580610A1 Diaminotriazole compounds useful as protein kinase inhibitors |
03/30/2006 | CA2579907A1 Carbo- and hetero-cyclic antibiotics and use thereof |
03/30/2006 | CA2578824A1 Crystalline form 2 of atrasentan hydrochloride |
03/30/2006 | CA2577818A1 New heterocyclic amides |
03/30/2006 | CA2543757A1 Paroxetine cholate or cholic acid derivative salts, and composition comprising paroxetine and cholic acid or cholic acid derivatives |
03/29/2006 | EP1640373A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
03/29/2006 | EP1638961A1 Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
03/29/2006 | EP1638960A2 Preparation of chemical compounds |
03/29/2006 | EP1638959A1 5ht -4 -antagonistic 4-(aminomethyl)-piperidine benzamides |
03/29/2006 | EP1638958A1 Zwitterionic non-linear optophores and devices incorporating same |
03/29/2006 | EP1638957A1 N-heterocyclyl phenyl-substituted cyclic ketoenols |
03/29/2006 | EP1638955A2 Pyrimidines useful as modulators of voltage-gated ion channels |
03/29/2006 | EP1638944A1 Tachykinin receptor antagonists |
03/29/2006 | EP1638943A2 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
03/29/2006 | EP1638942A1 Cis-2,4,5-triaryl-imidazolines |
03/29/2006 | EP1638934A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
03/29/2006 | EP1638564A1 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof as opioid receptors ligands |
03/29/2006 | EP1638560A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
03/29/2006 | EP1539745B1 N-aryl-2-oxazolidinones and their derivatives |
03/29/2006 | EP1330453B1 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
03/29/2006 | EP0837677B1 Brominated hexahydroxybiphenyl derivatives |
03/29/2006 | CN1753872A Process for the production of substituted nicotinic acid esters |
03/29/2006 | CN1753793A 成像系统 Imaging Systems |
03/29/2006 | CN1753670A Novel derivatives of benzimidazole and imidazo-pyridine and their use as medicaments |
03/29/2006 | CN1247546C Pyrazolinone derivatives |
03/29/2006 | CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia |
03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
03/29/2006 | CN1247541C Cyclic imines as pesticides |
03/28/2006 | US7019144 E.g. 1-(4-methanesulfonylphenyl)-5-phenyl-3-trifluoromethyl-1H-1,2,4-triazole; side effect reduction; antipyretics; analgesics; non-steroidal antiinflamatory agents; cyclooxygenase 2 inhibitors; anticarcinogenic agents; Alzheimer's disease; antiulcer agents; gastrointestinal disorders |
03/28/2006 | US7019137 Alkylation of 2,3-dihydro-1,4-benzodioxin-5-amine in chlorobenzene using trifluoromethanesulfonic acid salts of N,N-bis(2-chloroethyl)-alanine methyl ester, to form serotonin receptor antagonists; nervous system disorders |
03/28/2006 | US7019012 Quinazoline derivatives and pharmaceutical compositions containing them |
03/28/2006 | US7019011 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
03/28/2006 | US7019004 Agonists of imidazolidine-2,4-dione derivatives, chemical intermediates, for treating anxiety, depression, schizophrenia, neurodegenerative diseases, dementia, epilepsy, endocrinological disorders associated with excess of hormone, tumor |
03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
03/28/2006 | US7018988 Pharmaceutically active pyrrolidine derivatives as Bax inhibitors |
03/28/2006 | CA2263417C Arylalkanoylpyridazines |
03/28/2006 | CA2244862C Substituted amide derivatives |
03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
03/23/2006 | WO2006031852A1 Vanilloid receptor ligands and their use in treatments |
03/23/2006 | WO2006031782A2 Salvinorin derivatives as opioid receptor ligands |
03/23/2006 | WO2006031179A1 Process for preparation of phtalimide |
03/23/2006 | WO2006030984A1 Piperidine compound and process for preparing the same |
03/23/2006 | WO2006030975A1 Piperidine derivatives and use thereof |
03/23/2006 | WO2006030931A1 N-substituted n-(4-piperidinyl)amide derivative |
03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
03/23/2006 | WO2006030807A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
03/23/2006 | WO2006029912A1 Indole derivatives as antiviral agents |
03/23/2006 | WO2006029829A1 Heteroaroyl-substituted serine amides utilized as herbicides |
03/23/2006 | WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases |
03/23/2006 | WO2005095348A3 Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
03/23/2006 | WO2005082892A3 Triazole compounds as antibacterial agents and pharmaceutical compositions containing them |
03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
03/23/2006 | US20060063932 Aminoalkylpyrrolidine serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their synthesis |
03/23/2006 | US20060063931 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
03/23/2006 | US20060063825 Crystalline form of a drug |
03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
03/23/2006 | US20060063806 4-(4,5,6-trimethoxy-2-benzaldehyde) coumarin; fungicides, nontoxic |
03/23/2006 | US20060063801 Anticancer therapeutics; 3-(7-Methoxy-4-oxo-4H-1-benzopyran-2-yl)-1-phenyl-1H-1,4-dihydroquinolin-4-one |
03/23/2006 | US20060063796 Pyrazoles as inhibitors of tumor necrosis factor |
03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
03/23/2006 | US20060063780 Sodium channel blockers |
03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
03/23/2006 | US20060063758 Neuropeptide Y antagonist; antiarthritc agents; cardiovascular disorders; antidiabetic agents; kidney diseases; eating disorders; obesity |
03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
03/23/2006 | CA2579501A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
03/23/2006 | CA2579143A1 Vanilloid receptor ligands and their use in treatments |
03/23/2006 | CA2577181A1 Heteroaroyl-substituted serine amides utilized as herbicides |
03/23/2006 | CA2568832A1 Indole derivatives as antiviral agents |
03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
03/22/2006 | EP1636209A1 Epoxy compound and cured epoxy resin product |
03/22/2006 | EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors |
03/22/2006 | EP1636193A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
03/22/2006 | EP1636189A1 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
03/22/2006 | EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |